685 Artículos relativos a Drogas en Investigación

• New drug developments in the Latin Americas (Argentina, Costa Rica, Mexico and Panama).
  Publicado en Dis Nerv Syst
• New psychotropic drug developments in Denmark, Russia, and West Germany.
  Publicado en Dis Nerv Syst
• New drug development in United Kingdom.
  Publicado en Dis Nerv Syst
• New psychotropic drug developments in German speaking countries.
  Publicado en Dis Nerv Syst
• New drug development in France and French-speaking countries. Short and long acting neuroleptics.
  Publicado en Dis Nerv Syst
• New drug developments in the Netherlands. "Tetracyclic" psychotropic drugs.
  Publicado en Dis Nerv Syst
• Trials with drugs outside the United States.
  Publicado en Dis Nerv Syst
• Problems and experiences with drug trials outside the United States. The time lag in new drug availability.
  Publicado en Dis Nerv Syst
• The Physician Data Query (PDQ) cancer information system.
  Publicado en J Cancer Educ
• A very strict moral code is needed for the use of and experimentation with drugs.
  Publicado en Dolentium Hominum
• Regulatory hierarchies.
  Publicado en Mol Biother
• Food and Drug Administration guidelines for reproductive toxicity testing.
  Publicado en Reprod Toxicol
• Nonclinical pharmacologic and toxicologic considerations for evaluating biologic products.
  Publicado en Regul Toxicol Pharmacol
• Availability and timing of new drugs in Israel: analysis and international comparison.
  Publicado en J Clin Pharmacol
• New drugs: first time in man.
  Publicado en J Clin Pharmacol
• Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix. A Gynecologic Oncology Group study.
  Publicado en Invest New Drugs
• A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group study.
  Publicado en Invest New Drugs
• Phase II study of esorubicin (4'-deoxydoxorubicin) in advanced epithelial carcinoma of the ovary: a Gynecologic Oncology Group study.
  Publicado en Invest New Drugs
• Phase II trial of ICRF-187 in patients with acquired immune deficiency related Kaposi's sarcoma (AIDS-KS).
  Publicado en Invest New Drugs
• Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I study.
  Publicado en Invest New Drugs
• The investigative process for new drugs.
  Publicado en Ann Allergy
• Compassionate release of anti-HIV drugs.
  Publicado en Lancet
• FDA advisory committees and the new drug approval process.
  Publicado en J Clin Pharmacol
• Parallel track for investigational AIDS drugs.
  Publicado en Am J Hosp Pharm
• Oregistrerade preparat--så finner man information.
  Publicado en Lakartidningen
• Are health insurers denying patients quality care?.
  Publicado en J Natl Cancer Inst
• Drug access. Unclogging the pipeline.
  Publicado en Med World News
• The AIDS epidemic and clinical trials.
  Publicado en Acad Med
• Encephalopathy as a presentation of pediatric AIDS: case report.
  Publicado en Ann Allergy
• Computer program for handling investigational oncology drugs.
  Publicado en Am J Hosp Pharm
• A physician's guide to information available from the FDA about new drug approvals. The ACG Committee on FDA-related matters. American College of Gastroenterology.
  Publicado en Am J Gastroenterol
• Antimicrobial therapy for pediatric patients.
  Publicado en Pediatr Clin North Am
• Antiasthmatic therapy in children.
  Publicado en Pediatr Clin North Am
• Row over controversial new AIDS drug.
  Publicado en Nature
• AIDS drug brings providers challenge of distribution.
  Publicado en Mod Healthc
• Impact of third-party reimbursement on cancer clinical investigation: a consensus statement coordinated by the National Cancer Institute.
  Publicado en J Natl Cancer Inst
• FDA approves wider use of aerosolized pentamidine to prevent pneumocystis pneumonia.
  Publicado en Oncology (Williston Park)
• FDA approves treatment IND protocol for use of erythropoietin product in AIDS.
  Publicado en Clin Pharm
• FDA approves marketing of two drugs previously available under treatment IND regulations.
  Publicado en Clin Pharm
• Purine metabolism as a target for leukemia chemotherapy.
  Publicado en Blood Rev
• Influence des traitements médicamenteux sur le cycle veille-sommeil. Moyens d'investigation.
  Publicado en C R Seances Soc Biol Fil
• Immunobiologics and drugs available from the Centers for Disease Control.
  Publicado en J Pharm Technol
• Equitable access to biomedical advances: getting beyond the rights impasse.
  Publicado en Conn Law Rev
• Faith (healing), hope and charity at the FDA: the politics of AIDS drug trials.
  Publicado en Villanova Law Rev
• Use of investigational drugs as initial therapy for childhood solid tumors.
  Publicado en Haematol Blood Transfus
• Treating seriously ill patients with experimental drugs.
  Publicado en Pharm Res
• New natural products in cancer chemotherapy.
  Publicado en J Clin Pharmacol
• Disease, drugs, and delay: suggested changes for the FDA.
  Publicado en Clin Res
• Parallel track: where should it intersect science?.
  Publicado en Science
• Coping with investigational therapy.
  Publicado en Oncol Nurs Forum
• Advances in antineoplastic therapy.
  Publicado en Oncol Nurs Forum
• How drugs get to market.
  Publicado en Drug Ther Bull
• The federal regulation of prescription drug advertising and promotion.
  Publicado en JAMA
• Additional funding for AIDS drugs.
  Publicado en J Pract Nurs
• Methodological issues in AIDS clinical trials. Statutory and regulatory framework for drug approval.
  Publicado en J Acquir Immune Defic Syndr
• Globalization of the pharmaceutical industry: opportunities for physicians in clinical research.
  Publicado en J Clin Pharmacol
• Noncompliance in AIDS research.
  Publicado en Hastings Cent Rep
• Geriatric medications in the pipeline.
  Publicado en Health Aff (Millwood)
• Drug approval and AIDS: benefits for the elderly.
  Publicado en Health Aff (Millwood)
• Use of unproven and unapproved drugs to treat cocaine addiction.
  Publicado en Am J Psychiatry
• PHS proposes 'parallel track' for new AIDS drugs.
  Publicado en Public Health Rep
• AIDS and FDA drug-approval policy: an evolving controversy.
  Publicado en J Health Soc Policy
• Three reports at ASCO show ondansetron to be a very effective antiemetic with few side effects.
  Publicado en Oncology (Williston Park)
• Current treatment for human immunodeficiency virus infection.
  Publicado en Ear Nose Throat J
• Melagenina. An analysis of published and other available data.
  Publicado en Dermatologica
• FDA regulations provide broader access to unapproved drugs.
  Publicado en J Clin Pharmacol
• From the Food and Drug Administration.
  Publicado en JAMA
• Insurance coverage for investigational therapy.
  Publicado en J Natl Cancer Inst
• Public Health Service proposes policy for parallel-track drug access program.
  Publicado en Clin Pharm
• New rules for new drugs: the challenge of AIDS to the regulatory process.
  Publicado en Milbank Q
• From the Food and Drug Administration.
  Publicado en JAMA
• New rules for physicians implement sample drug bill.
  Publicado en Tex Med
• Potential role of hospital pharmacy in the handling and distribution of diagnostic radiopharmaceuticals.
  Publicado en Am J Hosp Pharm
• Parallel track expedites access to anti-AIDS drugs.
  Publicado en Am Fam Physician
• Biopharmaceutical payment and coverage: are cost control policies too restrictive? Industrial Biotechnology Association.
  Publicado en Healthspan
• N of 1 randomized trials for investigating new drugs.
  Publicado en Control Clin Trials
• Coexisting major depression and obsessive-compulsive disorder treated with venlafaxine.
  Publicado en J Clin Psychopharmacol
• Breakout II. Reimbursement concerns.
  Publicado en Cancer
• Reimbursement issues in cancer clinical trials.
  Publicado en Cancer
• Comparison of two cytotoxicity assays--tetrazolium derivative reduction (MTT) and tritiated thymidine uptake--on three malignant mouse cell lines using chemotherapeutic agents and investigational drugs.
  Publicado en Anticancer Res
• When is a drug 'safe'?.
  Publicado en Nature
• Pill hoarding and hypercompliance.
  Publicado en Clin Pharmacol Ther
• Trials and tribulations of AIDS drug testing.
  Publicado en Science
• New B-M group 'AIDS' drug for 'investigational use'.
  Publicado en Nurs RSA
• Development of beta-lactamase inhibitors.
  Publicado en J Reprod Med
• Alternative therapies in HIV infection.
  Publicado en AIDS
• Applying drug-use evaluation principles to investigational or unlabeled drug use.
  Publicado en Am J Hosp Pharm
• Compound Q. AIDS drug trial resumes.
  Publicado en Nature
• FDA's compassion for desperate drug companies.
  Publicado en Hastings Cent Rep
• Regulatory demands for cost-benefit studies.
  Publicado en Am Heart J
• Payment for drug therapy.
  Publicado en Physician Exec
• Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.
  Publicado en J Clin Oncol
• Evaluation of new drugs in untreated patients with small-cell lung cancer: its time has come.
  Publicado en J Clin Oncol
• Use of a personal computer to support an investigational drug service.
  Publicado en Hosp Pharm
• Comparing fact sheets and lectures to provide investigational drug information.
  Publicado en J Nurs Staff Dev
• Treatment of acute colonic pseudoobstruction (Ogilvie's syndrome) with cisapride.
  Publicado en Gastroenterology
• The OTC drug approval process. The ACG Committee on FDA-Related Matters. American College of Gastroenterology.
  Publicado en Am J Gastroenterol
• Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer.
  Publicado en J Clin Oncol
• Surfactant for premature infants with respiratory distress.
  Publicado en Med Lett Drugs Ther
• Community-based AIDS research.
  Publicado en Eval Rev